Market Gains, Nordstrom Deal, Trump's Team, Zepbound Shortage Ends

Business News

Market Gains, Nordstrom Deal, Trump's Team, Zepbound Shortage Ends
STOCK MARKETNORDSTROMDONALD TRUMP
  • 📰 NBCDFW
  • ⏱ Reading Time:
  • 57 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 43%
  • Publisher: 63%

The Dow Jones Industrial Average saw modest gains, while Nordstrom finalized a deal to go private. Donald Trump continues to shape his team, and the shortage of Eli Lilly's weight loss drug Zepbound has ended.

Streaming 24/7: Watch NBC 5 local news and weather for free wherever you areDow Jones Industrial Average

, meanwhile, had a smaller gain, adding just 66.69 points higher, or 0.16%. Trading was light Monday, which is expected to continue today. The market will close at 1 p.m. for the Christmas Eve holiday. Followworth roughly $6.25 billion from members of the founding Nordstrom family and the Mexican department store El Puerto de Liverpool. The family will have majority ownership of the private company, with 50.1%, while Liverpool will own 49.9%. Common shareholders, meanwhile, will receive $24.

The FDA said tirzepatide, the main ingredient in Eli Lilly's weight loss drug Zepbound, is no longer in shortage. That means patients will likely be unable to access compounded — or cheaper, off-brand — versions of the drug that compounding pharmacies were legally allowed to make during the shortage. Six patients told CNBC that they're worried about the price of the brand-name medicine.

5 ‘very profitable' side hustles to make extra cash during the holidays—one pays up to $700 for two hours of work I interviewed over 100 parents and top researchers: The No. 1 key takeaway about raising resilient kids

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NBCDFW /  🏆 288. in US

STOCK MARKET NORDSTROM DONALD TRUMP DRUG SHORTAGE ELI LILLY

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Nordstrom to Be Acquired for $6.25 Billion by Nordstrom Family, Mexican GroupNordstrom to Be Acquired for $6.25 Billion by Nordstrom Family, Mexican GroupNordstrom Inc. has agreed to be taken private in a $6.25 billion deal led by members of the Nordstrom family and a Mexican retail group. Shareholders will receive $24.25 per share.
Read more »

Nordstrom to be acquired by Nordstrom family and a Mexican retail group for $6.25 billionNordstrom to be acquired by Nordstrom family and a Mexican retail group for $6.25 billionCentury-old department store Nordstrom has agreed to be acquired and taken private by Nordstrom family members and a Mexican retail group for $6.25 billion, the company said Monday.
Read more »

Nordstrom to be acquired by Nordstrom family and a Mexican retail group in $6.25 billion dealNordstrom to be acquired by Nordstrom family and a Mexican retail group in $6.25 billion dealCentury-old department store Nordstrom has agreed to be acquired and taken private by Nordstrom family members and a Mexican retail group in a $6.25 billion deal with the industry being squeezed by discount chains and other competition.
Read more »

Nordstrom to be acquired by Nordstrom family and a Mexican retail group in $6.25 billion dealNordstrom to be acquired by Nordstrom family and a Mexican retail group in $6.25 billion dealCentury-old department store Nordstrom has agreed to be acquired and taken private by Nordstrom family members and a Mexican retail group in a $6.25 billion deal with the industry being squeezed by discount chains and other competition.
Read more »

Zepbound results in more weight loss than Wegovy in trial, Eli Lilly saysZepbound results in more weight loss than Wegovy in trial, Eli Lilly saysBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »

Zepbound leads to more weight loss than Wegovy, study findsZepbound leads to more weight loss than Wegovy, study findsStudy participants treated with Zepbound lost 20% of their body weight.
Read more »



Render Time: 2025-02-15 04:30:44